Yersinia Infection (Plague)
Overview
Plague is a serious bacterial infection caused by Yersinia pestis, a gram‑negative bacillus that primarily infects rodents and the fleas that feed on them. Humans become accidental hosts when they are bitten by an infected flea, inhale aerosolized bacteria, or come into direct contact with tissues of infected animals.
Three clinical forms are recognized:
- Bubonic plague – the classic form characterized by painful, swollen lymph nodes (buboes).
- Pneumonic plague – infection of the lungs; can be transmitted from person to person via respiratory droplets.
- Septicemic plague – bacteria spread in the bloodstream, leading to severe systemic illness.
Although plague is now rare in most high‑income countries, it remains endemic in parts of Africa, Asia, and the western United States. The World Health Organization (WHO) reports roughly 2,000–3,000 cases worldwide each year, with a case‑fatality rate of 30–60 % if untreated, but <90 % when appropriate antibiotics are given promptly.
Anyone who lives, works, or travels in plague‑endemic regions—or who handles rodents, fleas, or wildlife carcasses—can be at risk.
Symptoms
Symptoms vary according to the clinical form and the stage of disease. Below is a complete list with typical onset times.
Bubonic Plague
- Sudden fever (often >38.5 °C / 101.5 °F) and chills.
- Headache and malaise.
- Painful, swollen lymph nodes (buboes) that develop 1–4 days after the bite; commonly located in the groin, armpit, or neck.
- Fever may be accompanied by weakness, muscle aches, and loss of appetite.
Pneumonic Plague
- High fever and chills that appear abruptly.
- Severe cough producing bloody or watery sputum.
- Chest pain, shortness of breath, and rapid breathing.
- Headache, dizziness, and confusion may develop quickly.
- Symptoms can progress to respiratory failure within 24–48 hours.
Septicemic Plague
- Sudden fever, chills, abdominal pain, and vomiting.
- Bleeding from gums, nose, or puncture sites (a sign of disseminated intravascular coagulation).
- Darkening of the skin (purpura) and rapid development of shock.
- Potentially leads to organ failure if not treated within hours.
Other Possible Features (any form)
- Enlarged spleen or liver.
- Joint pain (arthralgia).
- Skin lesions (especially with septicemic plague).
Causes and Risk Factors
What Causes Plague?
Yersinia pestis is maintained in an enzootic cycle involving wild rodents (e.g., ground squirrels, rats) and their ectoparasites, primarily the Oriental rat flea (Xenopsylla cheopis). Humans become infected through:
- Flea bite (most common for bubonic plague).
- Inhalation of respiratory droplets from a person or animal with pneumonic plague.
- Direct contact with infected animal tissue or blood (e.g., hunting, skinning, or handling carcasses).
Who Is at Higher Risk?
- Residents of rural or semi‑urban areas where plague‑endemic rodents thrive (e.g., the western U.S., Madagascar, the Democratic Republic of Congo).
- People working in wildlife, veterinary, or pest‑control fields.
- Travelers to endemic regions, especially during the warm season when flea activity peaks.
- Individuals with weakened immune systems (HIV, cancer chemotherapy, organ transplant recipients).
- Persons living in crowded shelters or refugee camps where hygiene is poor, facilitating flea infestations.
Diagnosis
Prompt diagnosis is critical because the disease can become fatal within 24–48 hours. Clinicians combine exposure history, physical exam, and laboratory tests.
Laboratory Tests
- Blood cultures – Gold standard for septicemic plague; positive in >70 % of cases if drawn before antibiotics.
- Buboes aspirate or biopsy – Gram‑negative rods seen on Gram stain; culture confirms.
- Sputum culture or PCR – Required for pneumonic plague; PCR offers rapid detection (hours vs days for culture).
- Serology – Detection of anti‑Yersinia antibodies; useful for retrospective diagnosis but not for acute management.
- Rapid antigen tests – Limited availability, primarily used in outbreak investigations.
Imaging
- Chest X‑ray or CT scan for pneumonic plague shows infiltrates or lobar consolidation.
- Ultrasound/CT may help locate deep or atypical buboes.
Clinical Criteria
In endemic areas, a “clinical case definition” (fever + painful lymphadenopathy or pneumonia + exposure history) often triggers presumptive treatment while waiting for laboratory confirmation.
Treatment Options
Effective therapy hinges on early antibiotic administration. The choice depends on the clinical form, patient’s age, pregnancy status, and antibiotic allergies.
First‑Line Antibiotics
- Streptomycin 1 g intramuscularly (IM) every 12 hours for 7–10 days – historic gold standard.
- Gentamicin 5 mg/kg IV/IM daily for 7–10 days – preferred where streptomycin is unavailable.
- Doxycycline 100 mg PO/IV twice daily for 10–14 days – effective for mild-to-moderate disease and in children >8 years.
- Ciprofloxacin 500 mg PO twice daily for 10–14 days – useful for patients intolerant to aminoglycosides.
Alternative or Adjunctive Therapies
- Chloramphenicol – an option for meningitis or when other agents are contraindicated.
- Supportive care (IV fluids, oxygen, vasopressors) for septic shock or respiratory failure.
- Isolation precautions for pneumonic plague (droplet & contact precautions).
Lifestyle & Supportive Measures
- Rest and adequate hydration.
- Monitoring temperature and blood pressure at home.
- Avoiding self‑medication and completing the full antibiotic course.
Living with Yersinia Infection (Plague)
Most patients recover fully when treatment is timely, but a period of convalescence and preventive practices is essential.
Recovery Tips
- Follow-up visits – Repeat cultures or PCR at 48–72 hours to ensure bacterial clearance.
- Gradual return to activity – Start with light walks, avoid heavy lifting for at least 2 weeks.
- Nutrition – Protein‑rich foods (lean meat, legumes, dairy) aid tissue repair.
- Wound care – Keep any residual buboes clean; use antiseptic dressings as directed.
- Psychological support – Experiencing a serious infection can cause anxiety; counseling or support groups may help.
Monitoring for Late Complications
Even after successful treatment, patients should watch for:
- Persistent lymph node swelling (may require drainage).
- Chronic fatigue or joint pain (post‑infectious inflammatory response).
- Signs of secondary infection (redness, increased pain, fever).
Prevention
Because plague is a zoonosis, control strategies target both animal reservoirs and human exposure.
Personal Protective Measures
- Avoid handling dead rodents or squirrels; if necessary, wear gloves and a mask.
- Use insect repellent containing DEET or picaridin on exposed skin.
- Wear long sleeves and pants in flea‑infested areas.
- Keep pets (especially cats) free of fleas; use veterinarian‑approved flea control.
- Wash hands thoroughly after outdoor activities or contact with animals.
Environmental Controls
- Reduce rodent habitats by clearing brush, storing food in sealed containers, and sealing building cracks.
- Apply insecticides to rodent burrows and indoor spaces when infestation is known.
- Public‑health authorities may conduct rodent surveillance and flea‑control campaigns in endemic regions.
Vaccination & Prophylaxis
No licensed human plague vaccine is available in the United States, though experimental candidates exist. In outbreak settings, prophylactic antibiotics (e.g., doxycycline 100 mg PO daily for 7 days) are recommended for close contacts of a confirmed case.
Complications
If left untreated or if treatment is delayed, plague can lead to severe, life‑threatening complications.
- Septic shock – profound hypotension, multi‑organ failure.
- Acute respiratory distress syndrome (ARDS) – especially with pneumonic plague.
- Gangrene of affected limbs due to vascular thrombosis.
- Meningitis – bacteria spread to the central nervous system.
- Permanent lymph node scarring – may cause chronic swelling.
- Long‑term pulmonary fibrosis after severe pneumonic plague.
When to Seek Emergency Care
Immediate medical attention is required if you experience any of the following:
- Sudden high fever (>39 °C / 102 °F) with chills.
- Severe, throbbing pain and rapid swelling of a lymph node (bubo) that becomes red, warm, or oozing.
- Persistent cough producing bloody sputum, shortness of breath, or chest pain.
- Signs of shock – low blood pressure, rapid weak pulse, confusion, or fainting.
- Bleeding from gums, nose, or skin punctures, or dark purple spots on the skin.
- Rapidly worsening weakness, dizziness, or inability to stay awake.
Call emergency services (e.g., 911 in the U.S.) and inform them that you suspect “plague” or “possible Yersinia infection.” Early antibiotics dramatically improve survival.
References
- World Health Organization. Plague – Fact Sheet. 2022. https://www.who.int/news-room/fact-sheets/detail/plague
- Centers for Disease Control and Prevention. Plague (Yersinia pestis) – Epidemiology & Prevention. 2023. https://www.cdc.gov/plague/
- Mayo Clinic. Plague treatment: What you need to know. Updated 2024. https://www.mayoclinic.org/diseases-conditions/plague/diagnosis-treatment/drc-20352330
- Cleveland Clinic. Plague (Yersinia pestis) – Symptoms, Diagnosis, and Treatment. 2024. https://my.clevelandclinic.org/health/diseases/21162-plague
- National Institute of Allergy and Infectious Diseases (NIAID). Plague (Yersinia pestis) – Clinical Guidelines. 2023.
- Hinnebusch, B. J., & Zhan, X. (2021). The ecology of Yersinia pestis. Annual Review of Microbiology, 75, 181‑203. DOI:10.1146/annurev-micro-090419-104123